Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 33, 2330-2337, October 1, 1973]
© 1973 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Müller, W. E. G.
Right arrow Articles by Zahn, R. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Müller, W. E. G.
Right arrow Articles by Zahn, R. K.

Influence of Apurinic Acid on Programmed Synthesis in Different in Vitro Systems1

W. E. G. Müller, W. Hanske, A. Maidhof and R. K. Zahn

Institut für Physiologische Chemie, Universität, 65 Mainz, Johann-Joachim-Becher-Weg 13, West Germany

Apurinic acid (APA) obtained by mild acid hydrolysis of DNA was degraded to low-molecular-weight fragments. The fraction with an average molecular weight of 19,500 daltons reduced cell proliferation (L5178Y mouse lymphoma cells) on a molar basis more sensitively than did APA fractions of a lower molecular weight. Reduced cell proliferation was due to cytostatis rather than cytotoxicity. Cells treated with APA showed a 28% higher volume.

The DNA-dependent DNA polymerase (type II) is noncompetitively inhibited by APA, with fragments of 19,500 daltons exerting the highest inhibitory activity (with regard to molar basis). Treated APA, in which aldehyde groups have been reduced, shows a much lower inhibitory potency and acts competitively with untreated APA. The inhibition observed is caused by APA per se and not by secondary products of low molecular weight derived from APA. The DNA polymerases isolated from Escherichia coli (type I) and from oncogenic RNA viruses are not affected by APA. The influence of modified DNA on DNA-dependent RNA polymerase from L5178Y cells is low. No effect is observed in a protein-synthesizing, cell-free system. Among the nucleases tested, only the DNase I activity is inhibited by APA; this inhibition is competitive with respect to DNA.

A nuclease activity that degrades APA has been detected in APA-treated L5178Y cells. The action of this enzyme is discussed in relation to the recovery of cell proliferation in cells inhibited by APA.

1 The investigation was supported in part by Deutsche Forschungs gemeinschaft and by Fonds der Chemischen Industrie.

Received 2/13/73. Accepted 6/11/73.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1973 by the American Association for Cancer Research.